undamentalytics Newsletter

Cryo Cell International Inc cash flow statement

In fiscal 2025, Cryo Cell International Inc's operations generated $5.5m of cash; it spent $230,475 on capital projects, leaving free cash flow of $5.2m. It returned $3.2m in dividends and $169,502 through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Cryo Cell International Inc: cash flow statement, annual
Fiscal year2010Nov 20102011Nov 20112012Nov 20122013Nov 20132014Nov 20142015Nov 20152016Nov 20162017Nov 20172018Nov 20182019Nov 20192020Nov 20202021Nov 20212022Nov 20222023Nov 20232024Nov 20242025Nov 2025LTMAug 2026
Cash from operations21012556568899655
Depreciation and amortisation00000000000111111
Stock-based pay00100121001001100
Capital spending010000000102127200
Free cash flow200015565686−42455
Free cash flow after stock pay2−0−1014354586−41354
Dividends paid———————————080230
Share buybacks——2133110—1—02110—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: AMS vs CCELCCEL vs HAOAHG vs CCEL

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Cryo Cell International Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cryo Cell International Inc.